Intervention on New Onset-T1D Children

Recruiting N/A Interventional Study
Type 1 Diabetes
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
7 – 17
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
60 (estimated)
Sponsor
IRCCS San Raffaele · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

A pilot proof of concept clinical trial will be performed to demonstrate the restoration of gut barrier integrity by administration of beneficial anti-inflammatory gut microbial strains (Lactobacilli-enriched Vivomixx® probiotic) to new onset Type 1 Diabetes Children.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Clinical diagnosis of insulin-dependent type 1 diabetes * Positive for at least one islet autoantibody (ICA, GADA, IA-2, IAA, ZnT8) * No more than 3 months from first insulin injection * ≥ 7 to \< 18 year old Exclusion Criteria: * Diagnosed with celiac disease, IBD or other …
Contacts

Marika Falcone, MD

00390226434890

falcone.marika@hsr.it

CONTACT